Literature DB >> 33494765

Peptide enzyme-linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine.

Qi Wu1,2, Zhixian Lin1,2, Jinsen Wu1,2, Kun Qian1,2,3, Hongxia Shao1,2,3, Jianqiang Ye4,5,6,7,8, Aijian Qin9,10,11,12,13.   

Abstract

BACKGROUND: Infectious bronchitis virus (IBV), a coronavirus, is one of the most important poultry pathogens worldwide due to its multiple serotypes and poor cross-protection. Vaccination plays a vital role in controlling the disease. The efficacy of vaccination in chicken flocks can be evaluated by detecting neutralizing antibodies with the neutralization test. However there are no simple and rapid methods for detecting the neutralizing antibodies.
RESULTS: In this study, a peptide enzyme-linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine was developed. The pELISA could indirect evaluate neutralizing antibody titers against different types of IBV in all tested sera. The titers measured with the pELISA had a coefficient of 0.83 for neutralizing antibody titers.
CONCLUSIONS: The pELISA could detect antibodies against different types of IBV in all tested sera. The pELISA has the potential to evaluate samples for IBV-specific neutralizing antibodies and surveillance the infection of IBV.

Entities:  

Keywords:  Evaluation; Infectious bronchitis virus; Neutralizing antibody; Peptide ELISA

Mesh:

Substances:

Year:  2021        PMID: 33494765      PMCID: PMC7830047          DOI: 10.1186/s12917-021-02757-5

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.741


  44 in total

1.  Diagnostic Accuracy of Ultrasonography to Detect False Layers in a Commercial Laying Flock Infected by an Infectious Bronchitis Virus Delmarva Genotype Causing Cystic Oviducts.

Authors:  Eric Parent; Ariane Gagnon-Francoeur; Benoît Lanthier; Ghislain Hébert; Sébastien Buczinski; Martine Boulianne
Journal:  Avian Dis       Date:  2020-06       Impact factor: 1.577

Review 2.  ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.

Authors:  Alexander P Ivanov; Eugenia M Dragunsky
Journal:  Expert Rev Vaccines       Date:  2005-04       Impact factor: 5.217

3.  Inactivated infectious bronchitis virus vaccine encapsulated in chitosan nanoparticles induces mucosal immune responses and effective protection against challenge.

Authors:  Priscila Diniz Lopes; Cintia Hiromi Okino; Filipe Santos Fernando; Caren Pavani; Viviane Mariguela Casagrande; Renata F V Lopez; Maria de Fátima Silva Montassier; Helio José Montassier
Journal:  Vaccine       Date:  2018-04-10       Impact factor: 3.641

4.  Development and application of a Saccharomyces cerevisiae-expressed nucleocapsid protein-based enzyme-linked immunosorbent assay for detection of antibodies against infectious bronchitis virus.

Authors:  Aliandra M Gibertoni; Maria de Fátima S Montassier; Janete A D Sena; Patrícia E N Givisiez; Cibele R A G Furuyama; Hélio J Montassier
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Identification of Novel Linear Epitopes Located in the Infectious Bronchitis Virus Spike S2 Region.

Authors:  Kiyohiko Andoh; Kanako Ashikaga; Kiyotaka Suenaga; Shun Endo; Kenichi Yamazaki
Journal:  Avian Dis       Date:  2018-06       Impact factor: 1.577

6.  Relationship between sequence variation in the S1 spike protein of infectious bronchitis virus and the extent of cross-protection in vivo.

Authors:  D Cavanagh; M M Elus; J K Cook
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

Review 7.  Infectious Bronchitis Virus Variants: Molecular Analysis and Pathogenicity Investigation.

Authors:  Shu-Yi Lin; Hui-Wen Chen
Journal:  Int J Mol Sci       Date:  2017-09-22       Impact factor: 5.923

8.  Two novel neutralizing antigenic epitopes of the s1 subunit protein of a QX-like avian infectious bronchitis virus strain Sczy3 as revealed using a phage display peptide library.

Authors:  Nianli Zou; Jing Xia; Fuyan Wang; Zhenzhen Duan; Dan Miao; Qigui Yan; Sanjie Cao; Xintian Wen; Ping Liu; Yong Huang
Journal:  Vet Immunol Immunopathol       Date:  2015-08-19       Impact factor: 2.046

Review 9.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

10.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

Authors:  Alexandra C Walls; Young-Jun Park; M Alejandra Tortorici; Abigail Wall; Andrew T McGuire; David Veesler
Journal:  Cell       Date:  2020-03-09       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.